GLP-1 receptor agonists were originally developed for the treatment of type 2 diabetes, and later of obesity, but there is growing evidence that their benefits extend far beyond reductions in blood ...
Globally, the prevalence of adolescents experiencing symptoms of anxiety and depression has been rising steeply in the past two decades,1 and diagnoses continue to increase.2 Symptoms of anxiety and ...
Christy Fischer has never felt lost or sorry for herself during the 18 years since her diagnosis with stage IV lung cancer.
During the 16th and 18th centuries, scurvy, a disease caused by insufficient vitamin C intake, affected millions of sailors due to scarcity of fruits and vegetables during long voyages. Three ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. While the world's attention ...
Copyright: © 2024 Elsevier Ltd. Published by Elsevier Ltd. Russia's invasion has disrupted medical research in Ukraine, but many scientists are finding ways to ...
aDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium bDepartment of Public Health, Institute of Tropical Medicine, Antwerp, Belgium cDepartment of Biomedical Sciences, ...
Copyright: © 2022 The Author(s). Published by Elsevier Ltd. Anthropogenic climate change has induced considerable harm to women's rights, health, and livelihoods ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Advances in preoperative ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The Abyei Area ...
Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Copyright: © 2024 Elsevier Ltd. Published by Elsevier Ltd. The 2024 Access to Medicine Index shows that some manufacturers are increasingly prioritising LMICs, but ...